UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stock Holdings in Omega Healthcare Investors, Inc. $OHI

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) by 0.5% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 2,114,655 shares of the real estate investment trust’s stock after selling 10,743 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Omega Healthcare Investors were worth $100,827,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in OHI. Van ECK Associates Corp boosted its stake in shares of Omega Healthcare Investors by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 199,170 shares of the real estate investment trust’s stock worth $9,496,000 after acquiring an additional 33,211 shares in the last quarter. Hsbc Holdings PLC increased its stake in Omega Healthcare Investors by 52.3% in the 2nd quarter. Hsbc Holdings PLC now owns 926,367 shares of the real estate investment trust’s stock valued at $44,398,000 after purchasing an additional 318,146 shares in the last quarter. Kingsview Wealth Management LLC purchased a new position in Omega Healthcare Investors in the 2nd quarter valued at approximately $677,000. Beacon Pointe Advisors LLC acquired a new position in Omega Healthcare Investors during the second quarter worth $635,000. Finally, Empowered Funds LLC acquired a new position in Omega Healthcare Investors during the second quarter worth $2,712,000. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $46.77 on Wednesday. Omega Healthcare Investors, Inc. has a fifty-two week low of $39.26 and a fifty-two week high of $52.39. The company has a market capitalization of $14.17 billion, a price-to-earnings ratio of 16.70, a PEG ratio of 1.85 and a beta of 0.58. The stock has a fifty day moving average of $48.36 and a two-hundred day moving average of $47.10.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.68. The business had revenue of $328.25 million for the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a return on equity of 15.76% and a net margin of 66.96%.The business’s revenue was up 16.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.77 earnings per share. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, analysts forecast that Omega Healthcare Investors, Inc. will post 3.12 EPS for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were paid a dividend of $0.68 per share. The ex-dividend date of this dividend was Monday, August 3rd. This represents a $2.72 annualized dividend and a dividend yield of 5.8%. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s dividend payout ratio is 97.14%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on OHI shares. UBS Group set a $47.00 target price on Omega Healthcare Investors in a report on Thursday, June 18th. Barclays cut their price target on Omega Healthcare Investors from $51.00 to $50.00 and set an “underweight” rating for the company in a research note on Monday. Raymond James Financial began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 price objective on the stock. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Finally, Scotiabank cut their target price on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Six investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $49.50.

Check Out Our Latest Stock Analysis on Omega Healthcare Investors

About Omega Healthcare Investors

(Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Featured Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.